| CAS: | 2363144-29-8 | ||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||
| 918091 | Sigma-Aldrich | Lenalidomide-Photoswitch2-NH2 hydrochloride | ≥95% | 5462.51元/50 MG; | 展开 | ||||||||||||||||||||||||
产品说明 应用 Protein degrader building block Lenalidomide-Photoswitch2-NH2 hydrochloride enables the synthesis of PHOtochemically TArgeting Chimeras (PHOTACs), or photoswitchable proteolysis-targeting chimeras (PROTACs) that can be reversibly activated with different wavelengths of light. Developed in the Trauner and Pagano labs, PHOTACs are inactive in the dark but are activated to the cis isomer via irradiation at 390 nm and reversibly deactivated at wavelengths above 450 nm. As described in Reynders et al, this conjugate was used to prepare PHOTAC-II-5 and contains a Cereblon (CRBN)-recruiting ligand, an azobenzene photoswitchable crosslinker, and pendant amine for reactivity with an acid on the target warhead. Light-mediated control of the resulting PHOTAC affords advanced temporal and spatial control of targeted protein degradation.
Low-intensity light needed for photoactivation is not cytotoxic. Browse our full offering of degrader building blocks that streamlines the synthesis of degrader libraries. 其他说明 Technology Spotlight: Degrader Building Blocks for Targeted Protein Degradation 法律信息 PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||